国产凌凌漆

香港中医医院服务扩展　将推出24小时住院服务_我的网站

A |     

    Latest newsA court in Wuhan, Central China's Hubei Province, has sentenced a man surnamed Xia and his son to six years and five and a half years in prison, respectively, for selling controlled stimulant substances. The verdict followed a two-year police investigation, which was initiated after China's Ministry of Public Security received a tip-off from the US Drug Enforcement Administration (DEA), Chinese Central Television (CCTV) reported on Tuesday.
The case dates back to June 2023, when the US DEA, operating under the Department of Justice, notified China's MPS of an arrest involving a Chinese national charged with trafficking sensitive chemicals. The MPS subsequently directed public security authorities in Hubei to launch an investigation.
Further investigations found Xia and his son had sold and shipped large quantities of non-scheduled precursor chemicals overseas.
Beginning in May 2021, the two suspects registered several shell trading companies and hired employees to fabricate information about the companies' production, business and transportation capabilities on domestic and overseas websites. 
They posted large numbers of advertisements for non-scheduled chemicals, sourced the products domestically after receiving orders from overseas buyers, and shipped them abroad through international freight forwarding companies, according to the CCTV report.
During a two-year investigation, police found that some of the chemicals sold by the duo included stimulant substances controlled under Chinese regulations.
The court found that Xia and his son organized others to illegally sell controlled stimulant substances in 123 transactions between November 2021 and July 2024, with total sales exceeding 1.69 million yuan ($235,000).
On August 14, 2026, the court convicted both defendants of illegal business operations, sentencing Xia to six years in prison and his son to five years and six months. Both were also fined.
Police reminded companies and individuals engaged in chemical trading and export businesses to strengthen their legal awareness, strictly comply with relevant Chinese and foreign laws and regulations, and follow warning notices issued by China's national anti-drug authorities in August 2019, November 2023, November 2025 and May 2026 to guard against legal risks.
Global Times
。      香港8月25日电（郭辛）香港特区政府医务卫生局与香港中医医院营运机构25日举行联合记者会，公布香港中医医院服务扩展计划，将分阶段开展24小时住院服务。

B |   香港中医医院行政总监卞兆祥在会上介绍，医院将于今年12月11日起分阶段开展24小时住院服务。首阶段设有93张住院病床、20张临床试验及研究中心病床和2张加护病床。预计至2030年底，医院提供的病床总数将达到400张。  据悉，24小时住院服务主要面向病情复杂、需要24小时临床监察、暂时丧失自理能力或需接受密集式治疗的患者。患者可经由院内门诊或其他医疗机构转介。住院服务采用“中西医协作”模式，由中医师与西医共同会诊。

C |   香港特区政府医务卫生局局长卢宠茂表示，作为香港中医药旗舰机构，香港中医医院自投入运营以来，在医疗服务、教学培训、科研创新、多方协作及创造健康价值等方面取得良好进展。医院运营8个多月来，已四度增加政府资助门诊服务名额，以回应市民的殷切需求。  香港中医医院2025年12月11日正式投入运营，全面开展涵盖中医内科、外科、妇科、儿科、骨伤科及针灸科在内的六大分科服务。

Current article:http://maigaiengsheipilongnukenjin.buzz/news/20260826_507.html

Published on:03:48:29